Search the GHTC website

Global health R&D delivers for Wyoming

US government investment in global health R&D has delivered

$596 thousand
to Wyoming research institutions
Global health R&D at work in Wyoming

University of Wyoming (UW) researchers are studying how the HIV virus disarms the body’s ability to create an immune response. Infection with HIV results in a profound and selective loss of CD4+ T cells, an essential part of the human immune system. Although HIV has a direct effect on these cells, the virus also causes large numbers of uninfected cells to undergo a process of cell suicide that is critical to many normal functions. The UW scientists are investigating the complex interaction between HIV, CD4+ T cells, and HIV-induced cell death. Results of the research could lead to improved treatments for AIDS and other HIV-related co-infections. Since the beginning of the epidemic, at least 35 million people have died of AIDS. Sub-Saharan Africa remains the most severely affected, with nearly one in every 25 adults in the region living with HIV.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Case study photo: 2011, Charlotte Raymond Photography for International AIDS Vaccine Initiative (IAVI)